QHSLab, Inc. operates as a medical device technology and software as a service company. The company is headquartered in West Palm Beach, Florida and currently employs 4 full-time employees. The company went IPO on 2002-01-09. Its Quality Health System Lab Expert System (QHSLab), a digital healthcare platform, provides clinical decision support and point of care solutions and supports non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and is reimbursable to medical practice. The company also markets and sells point-of-care, rapid-response diagnostic tests used in primary care practice. QHSLab offers a variety of digital healthcare intervention programs including allergies and asthma, mental health, musculoskeletal health and pain, hypertension, sleep disorders, weight loss and much more. The firm sells allergy diagnostic-related products and immunotherapy treatments to physicians.
Follow-Up Questions
QHSLab Inc의 CEO는 누구입니까?
Mr. Troy Grogan은 2018부터 회사에 합류한 QHSLab Inc의 Chairman of the Board입니다.
USAQ 주식의 가격 성능은 어떻습니까?
USAQ의 현재 가격은 $0.15이며, 전 거래일에 decreased 0% 하였습니다.
QHSLab Inc의 주요 사업 주제나 업종은 무엇입니까?
QHSLab Inc은 N/A 업종에 속하며, 해당 부문은 N/A입니다
QHSLab Inc의 시가총액은 얼마입니까?
QHSLab Inc의 현재 시가총액은 $1.6M입니다
QHSLab Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 3명의 분석가가 QHSLab Inc에 대한 분석 평가를 실시했으며, 이는 2명의 강력한 매수, 4명의 매수, 1명의 보유, 0명의 매도, 그리고 2명의 강력한 매도를 포함합니다
